WEBSTER, TX
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)FOUNDATION FOR ADVANCES IN THERAPEUTICS AND PREVENTION, founded in 2005, is a micro nonprofit in the Medical Research sector that reported $93K in total revenue in fiscal year 2020. Revenue fell 24% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $93K, a strong 100% operating margin.
RESEARCH TO ADVANCE PREVENTION AND THERAPY OF INFECTIOUS AND CUTANEOUS.
THE FOUNDATION SUPPORTS RESEARCH TO DETERMINE THE MECHANISM BY WHICH VIRUSES CAUSE CANCER AND TEACHES BASIC LABORATORY TECHNIQUES TO STUDENTS SO THAT THEY MAY DEVELOP A CAREER IN MEDICAL RESEARCH.THE...
THE FOUNDATION SUPPORTS RESEARCH TO DETERMINE THE MECHANISM BY WHICH VIRUSES CAUSE CANCER AND TEACHES BASIC LABORATORY TECHNIQUES TO STUDENTS SO THAT THEY MAY DEVELOP A CAREER IN MEDICAL RESEARCH.THE FOUNDATION PROVIDES CONSULTATIONS AND PRESENTATIONS AS A PART OFTHIS PROGRAM.
THE LAB DOES TYPING OF HUMAN PAPILLOMAVIRUSES AT NO COST ON SAMPLES FROM AROUND THE WORLD. THE LAB ALSO PERFORMS MOLECULAR ANALYSIS TO DETERMINE GENETIC SUSCEPTIBILITIES TO VIRAL DISEASES AND TEACHES...
THE LAB DOES TYPING OF HUMAN PAPILLOMAVIRUSES AT NO COST ON SAMPLES FROM AROUND THE WORLD. THE LAB ALSO PERFORMS MOLECULAR ANALYSIS TO DETERMINE GENETIC SUSCEPTIBILITIES TO VIRAL DISEASES AND TEACHES BASIC MOLECULAR TECHNIQUES TO STUDENTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2020 | 2019 | Change | |
|---|---|---|---|
| Revenue | $93,497 | $123,179 | -0.2% |
| Expenses | $425 | $1,775 | -0.8% |
| Net Income | $93,072 | $121,404 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| STEPHEN K TYRING | PRESIDENT | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| DANIEL CARRASCO | OFFICER | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| MARIO QUINTANILLA | OFFICER | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2021 | $93,497 | $425 | $858,829 | $93,072 |
| 2020 | $123,179 | $1,775 | $765,757 | $121,404 |
| 2019 | $149,671 | $1,775 | $644,353 | $147,896 |
Compare FOUNDATION FOR ADVANCES IN THERAPEUTICS AND PREVENTION with other nonprofits in Texas and across the country.